Literature DB >> 8564948

Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate.

B An1, Q P Dou.   

Abstract

We had found that in an early stage of DNA damage-induced, p53-independent apoptosis, retinoblastoma (RB) protein is hypophosphorylated to a p115 form by an activated serine/threonine phosphatase. Here, we report that accompanying the internucleosomal fragmentation of DNA, the newly formed p115/hypo/RB was immediately cleaved into at least two fragments, p68 and p48. The RB cleavage activity possessed properties of interleukin 1 beta-converting enzyme family. Addition of a specific tetrapeptide interleukin 1 beta-converting enzyme inhibitor prevented cleavage of p115/hypo/RB and early apoptotic cells from undergoing further apoptosis. We suggest that activation of the RB phosphatase and protease may be involved in mediating the two physiological stages of apoptosis, commitment and execution, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564948

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein.

Authors:  J Doostzadeh-Cizeron; R Evans; S Yin; D W Goodrich
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.

Authors:  J L Nargi; R R Ratan; D E Griffin
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

4.  MMPs in unusual places.

Authors:  David M Hockenbery
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Authors:  S Oliverio; A Amendola; F Di Sano; M G Farrace; L Fesus; Z Nemes; L Piredda; A Spinedi; M Piacentini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

6.  Actin cleavage in various tumor cells is not a critical requirement for executing apoptosis.

Authors:  R L Rice; D G Tang; J D Taylor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor.

Authors:  N Inohara; T Koseki; S Chen; X Wu; G Núñez
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

8.  Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.

Authors:  Jian Zuo; Caifeng Bi; Yuhua Fan; Daniela Buac; Chiara Nardon; Kenyon G Daniel; Q Ping Dou
Journal:  J Inorg Biochem       Date:  2012-10-15       Impact factor: 4.155

9.  1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.

Authors:  Zhen Zhang; Caifeng Bi; Sara M Schmitt; Yuhua Fan; Lili Dong; Jian Zuo; Q Ping Dou
Journal:  J Biol Inorg Chem       Date:  2012-10-09       Impact factor: 3.358

10.  pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.

Authors:  J Bertin-Ciftci; B Barré; J Le Pen; L Maillet; C Couriaud; P Juin; F Braun
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.